HOLUBIAK MYRON Z
SEC insider (Form 3/4/5 filer). CIK 0001199080. Secretary at CITIUS ONCOLOGY, INC. (CTOR) and 1 other issuer. 14 reported Form 4/5 transactions since Sep 2024; latest on Sep 19, 2025. Located in CRANFORD, NJ.
Companies HOLUBIAK MYRON Z has filed insider reports for
- CITIUS ONCOLOGY, INC. (CTOR): Director, Officer, Secretary
- Citius Pharmaceuticals, Inc. (CTXR): Director, Officer, Vice Chairman
HOLUBIAK MYRON Z
CIK: 0001199080
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (14 total)
- Sep 19, 2025CTOR
CITIUS ONCOLOGY, INC.
AwardDirect850K shares- - Sep 19, 2025CTOR
CITIUS ONCOLOGY, INC.
AwardIndirect100K shares- - Aug 8, 2025CTXR
Citius Pharmaceuticals, Inc.
AwardDirectWarrant to Purchase Common Stock
22.3K shares- - Aug 8, 2025CTXR
Citius Pharmaceuticals, Inc.
DispositionDirectWarrant to Purchase Common Stock
31.4K shares- - Aug 8, 2025CTXR
Citius Pharmaceuticals, Inc.
AwardDirectWarrant to Purchase Common Stock
31.4K shares- - Aug 8, 2025CTXR
Citius Pharmaceuticals, Inc.
DispositionDirectWarrant to Purchase Common Stock
22.3K shares- - Dec 12, 2024CTOR
CITIUS ONCOLOGY, INC.
AwardDirectStock Option (Right to Buy)
300K shares- - Dec 12, 2024CTOR
CITIUS ONCOLOGY, INC.
AwardIndirectStock Option (Right to Buy)
50K shares- - Nov 7, 2024CTXR
Citius Pharmaceuticals, Inc.
AwardDirectStock Option (Right to Purchase Common Stock)
350K shares- - Nov 7, 2024CTXR
Citius Pharmaceuticals, Inc.
AwardIndirectStock Option (Right to Buy)
75K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 19, 2025 |  CTOR CITIUS ONCOLOGY, INC. | Award | 850,000 | - | - | Direct |
| Sep 19, 2025 | CTOR CITIUS ONCOLOGY, INC. | Award | 100,000 | - | - | Indirect |
| Aug 8, 2025 |  CTXR Citius Pharmaceuticals, Inc. | Award Warrant to Purchase Common Stock | 22,344 | - | - | Direct |
| Aug 8, 2025 | CTXR Citius Pharmaceuticals, Inc. | Disposition Warrant to Purchase Common Stock | 31,373 | - | - | Direct |
| Aug 8, 2025 | CTXR Citius Pharmaceuticals, Inc. | Award Warrant to Purchase Common Stock | 31,373 | - | - | Direct |
| Aug 8, 2025 | CTXR Citius Pharmaceuticals, Inc. | Disposition Warrant to Purchase Common Stock | 22,344 | - | - | Direct |
| Dec 12, 2024 | CTOR CITIUS ONCOLOGY, INC. | Award Stock Option (Right to Buy) | 300,000 | - | - | Direct |
| Dec 12, 2024 | CTOR CITIUS ONCOLOGY, INC. | Award Stock Option (Right to Buy) | 50,000 | - | - | Indirect |
| Nov 7, 2024 | CTXR Citius Pharmaceuticals, Inc. | Award Stock Option (Right to Purchase Common Stock) | 350,000 | - | - | Direct |
| Nov 7, 2024 | CTXR Citius Pharmaceuticals, Inc. | Award Stock Option (Right to Buy) | 75,000 | - | - | Indirect |
1-10 of 14 transactions